Here in the Maxson Laboratory, our primary goal is to understand how genomic changes manifest at the cellular level to promote blood cancer formation and progression. We are particularly interested in understanding how signaling and epigenetic dysfunction drive myeloid malignancies to enable the development of new treatment strategies for patients.
The Maxson Lab is supported by : The National Cancer Institute The National Heart, Lung and Blood Institute Blood Cancer United V Foundation Alex's Lemonade Stand Foundation Evans MDS The Andrew McDonough B+ Foundation The Vera and Joseph Dresner Foundation The Kuni Foundation The Knight Cancer Institute